Clinical Trial Update: Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting [Phase 4]

View source ↗

Summary

Phase 4 crossover study assessing AR11 efficacy in pediatric ADHD in a laboratory classroom setting; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• AR11

Snippet

Sponsor: Arbor Pharmaceuticals, Inc. | Conditions: Attention Deficit Hyperactivity Disorder (ADHD) | Phase 4 | Status: COMPLETED | Results posted: 2016-04-19